4//SEC Filing
Jafri Hasan 4
Accession 0001493152-23-021476
CIK 0001614067other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:11 PM ET
Size
9.3 KB
Accession
0001493152-23-021476
Insider Transaction Report
Form 4
Jafri Hasan
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-06-05+10,000→ 15,100 total - Award
Stock Options
2023-05-04+25,000→ 155,000 totalExercise: $0.16Exp: 2033-05-04→ Common Stock (25,000 underlying) - Exercise/Conversion
Restricted Stock Units
2023-06-05−10,000→ 10,000 total→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]50% of the options vest on the three month anniversary of the date of grant and the remainder vest on the six month anniversary of the date of grant.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]10,000 shares of Common Stock vested on June 5, 2023 and 10,000 will vest on 12/5/2023. In the event that the Reporting Person's employment is terminated without cause by the Issuer, the RSUs will immediately vest.
Documents
Issuer
Aridis Pharmaceuticals, Inc.
CIK 0001614067
Entity typeother
Related Parties
1- filerCIK 0001815352
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:11 PM ET
- Size
- 9.3 KB